TAZ-AS202 enhances aggressive properties of NSCLC cell lines, such as migration and invasion, by regulating a set of genes belonging to cancer-associated pathways, including WNT and EPH-Ephrin signaling. The gene discussed is EPHA1; the disease is cancer.